Donglu Zhao

Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial

Michael Wang, Hun Ju Lee, Hubert H. Chuang et al. · The Lancet Oncology · 2015 · 214 citations

Medicine, Oncology, Pharmacotherapy +10

Burden of lymphoma in China, 1990−2019: an analysis of the global burden of diseases, injuries, and risk factors study 2019

Weiping Liu, Jiangmei Liu, Yuqin Song et al. · Aging · 2022 · 44 citations · Full text

Medicine, Health Sciences, Oncology +17

A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China

Weiping Liu, Donglu Zhao, Ting Liu et al. · Frontiers in Oncology · 2021 · 22 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Detection and quantification of <i>Fusarium commune</i> in host tissue and infested soil using real‐time <scp>PCR</scp>

Zhen-Dong ZHU, Lu Zheng, Tom Hsiang et al. · Plant Pathology · 2015 · 15 citations · Full text

Life Sciences, Plant Biology, Plant Sciences +16

Extranodal diffuse large B‐cell lymphoma: Clinical and molecular insights with survival outcomes from the multicenter EXPECT study

Si‐Yuan Chen, Pengpeng Xu, Ru Feng et al. · Cancer Communications · 2025 · 11 citations · Full text

Medicine, Hematology, Oncology +15